Issues around Paxlovid – Part 1
from Modern Practice Podcast Hosted by Dr. Tom Villanueva and Vizient Medical Leadership Team
Available through an FDA Emergency Use Authorization (EUA), Paxlovid could be a approach to more effective treatment of the COVID-19 virus. On this episode, we begin a two-part discussion about the evidence from clinical trials of Paxlovid. Guest speaker: Stacy Lauderdale, PharmD, BCPS Senior Director, Drug Information Vizient Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Senior Principal, Clinical Operations and Quality Vizient Show Notes: [01:09] Defining Paxlovid [01:53] Paxlovid vs Tamiflu – comparison of effectiveness and impact [02:50] Two randomized control trials [04:42] Effectiveness with Omicron variant [07:19] Age as a risk factor [08:23] The issue of rebound Links | Resources: To contact Modern Practice: [email protected] Stacy’s email address: [email protected] 13 Things to Know about Paxlovid, the Latest COVID-19 Pill (Yale Medicine) Click here Subscribe Today! Apple Podcasts Amazon Podcasts Android Google Podcasts Spotify Stitcher RSS Feed
Embed this episode
No transcript yet.